The White House told TPM Monday that it will not heed those calls. “First and foremost, when you turn upside down the entire FDA approval process, you’re not talking about just mifepristone,” he said. You’re talking about our vaccines. You’re talking about insulin. There’s also the contradictory ruling out of Washington to consider, ordering the administration to keep mifepristone available for several states.

Source: Washington Post April 11, 2023 00:22 UTC